Residential College | false |
Status | 已發表Published |
Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases | |
Yang, Chao1; Rubin, Limor2; Yu, Xiyong3; Lazarovici, Philip4; Zheng, Wenhua1 | |
Source Publication | Medicinal Research Reviews |
ISSN | 0198-6325 |
2024-05-01 | |
Abstract | Adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) is a highly conserved eukaryotic enzyme discovered as a key regulator of cellular energy homeostasis, with anti-inflammation, antioxidative stress, anticancer, and antifibrosis beneficial effects. AMPK is dysregulated in human pulmonary diseases such as acute lung injury, nonsmall cell lung cancer, pulmonary fibrosis, chronic obstructive pulmonary disease, and asthma. This review provides an overview of the beneficial role of natural, synthetic, and Chinese traditional medicines AMPK modulators in pulmonary diseases, and highlights the role of the AMPK signaling pathway in the lung, emphasizing the importance of finding lead compounds and drugs that can target and modulate AMPK to treat the lung diseases. |
Keyword | Ali Ampk Copd Nsclc Pf |
Language | 英語English |
DOI | 10.1002/med.22014 |
URL | View the original |
Volume | 44 |
Issue | 3 |
Pages | 1326-1369 |
WOS ID | WOS:001143117700001 |
WOS Subject | Chemistry, Medicinal ; Pharmacology & Pharmacy |
WOS Research Area | Pharmacology & Pharmacy |
Indexed By | SCIE |
Scopus ID | 2-s2.0-85182487811 |
Fulltext Access | |
Citation statistics | |
Document Type | Review article |
Collection | Faculty of Health Sciences DEPARTMENT OF PHARMACEUTICAL SCIENCES |
Corresponding Author | Zheng, Wenhua |
Affiliation | 1.Faculty of Health Sciences, University of Macau, Taipa, Macao 2.Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel 3.School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China 4.School of Pharmacy Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel |
First Author Affilication | Faculty of Health Sciences |
Corresponding Author Affilication | Faculty of Health Sciences |
Recommended Citation GB/T 7714 | Yang, Chao,Rubin, Limor,Yu, Xiyong,et al. Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases[J]. Medicinal Research Reviews, 2024, 44(3), 1326-1369. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment